03. tbl. 109. árg. 2023
Resistant hypertension – pheochromocytoma
Krister Blær Jónsson1
Eiríkur Orri Guðmundsson2
Margrét Sigurðardóttir3
Jón Jóhannes Jónsson1,4
Helga Ágústa Sigurjónsdóttir1,5
1Faculty of Medicine, University of Iceland, 2department of urology, Landspítali National University Hospital of Iceland, 3department of pathology, Landspítali National University Hospital of Iceland, 4department of genetics, Landspítali National University Hospital of Iceland, 5department of internal medicine, Landspítali National University Hospital of Iceland.
Correspondence: Krister Blær Jónsson, kristerb@landspitali.is
Key words: pheochromocytoma, paraganglioma, resistant hypertension, neuroendocrine tumor, metanephrine.
We report a case of a man with a 30-year history of treatment-resistant hypertension, hydropoiesis, tachycardic spells and dysgeusia. Despite repeated visits to the emergency department and work-up in an out-patient clinic, the diagnosis was unknown. Three years prior to remittance to an endocrinologist, the hypertension worsened, and he developed diabetes type-II. Further work-up revealed a 3 cm extra-adrenal pheochromocytoma, a paraganglioma. After surgical removal of the tumor, he is without medication and symptom free.
Pheochromocytoma and paraganglioma are rare causes of hypertension, estimated to explain 0.1-0.6% of all cases, but nonetheless an important diagnosis to make, due to serious side effects.